Buscar
Mostrando ítems 1-10 de 12
The inclusion of rhodium(II)alpha-methyl-cinnamate in beta-cyclodextrin
(Kluwer Academic PublDordrechtHolanda, 1995)
Free rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy
(Jornal de Nanobiotecnologia, 2011)
Background: Rhodium (II) citrate (Rh2(H2cit)4) has significant antitumor, cytotoxic, and cytostatic activity on Ehrlich ascite tumor. Although toxic to normal cells, its lower toxicity when compared to carboxylate analogues ...
Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy
(2011-03-28)
Abstract
Background
Rhodium (II) citrate (Rh2(H2cit)4) has significant antitumor, cytotoxic, and cytostatic activity on Ehrlich ascite tumor. Although toxic to normal cells, ...
Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy
(2011-03)
Abstract
Background
Rhodium (II) citrate (Rh2(H2cit)4) has significant antitumor, cytotoxic, and cytostatic activity on Ehrlich ascite tumor. Although toxic to normal cells, its lower toxicity when compared to carboxylate ...
Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy
(2011-03-28)
Abstract
Background
Rhodium (II) citrate (Rh2(H2cit)4) has significant antitumor, cytotoxic, and cytostatic activity on Ehrlich ascite tumor. Although toxic to normal cells, ...
Electrochemical properties of Doyle catalyst immobilized on carbon paste in the presence of DNA
(Elsevier Science SaLausanneSuíça, 2000)
The Inclusion Of Rhodium(ii)α-methyl-cinnamate In β-cyclodextrin
(Kluwer Academic Publishers, 1995)